200 related articles for article (PubMed ID: 2733792)
1. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
Scolding NJ; Morgan BP; Houston WA; Linington C; Campbell AK; Compston DA
Nature; 1989 Jun; 339(6226):620-2. PubMed ID: 2733792
[TBL] [Abstract][Full Text] [Related]
2. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F; Shin ML
J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199
[TBL] [Abstract][Full Text] [Related]
3. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
Cid C; Alvarez-Cermeño JC; Salinas M; Alcázar A
J Neurochem; 2005 Oct; 95(2):349-60. PubMed ID: 16135098
[TBL] [Abstract][Full Text] [Related]
4. Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system.
Zajicek J; Wing M; Skepper J; Compston A
Lab Invest; 1995 Jul; 73(1):128-38. PubMed ID: 7541492
[TBL] [Abstract][Full Text] [Related]
5. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
Bartlett PF; Mackay IR
J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
[TBL] [Abstract][Full Text] [Related]
6. Reversible injury of cultured rat oligodendrocytes by complement.
Scolding NJ; Houston WA; Morgan BP; Campbell AK; Compston DA
Immunology; 1989 Aug; 67(4):441-6. PubMed ID: 2767708
[TBL] [Abstract][Full Text] [Related]
7. The complement system in central nervous system diseases.
Rus H; Cudrici C; David S; Niculescu F
Autoimmunity; 2006 Aug; 39(5):395-402. PubMed ID: 16923539
[TBL] [Abstract][Full Text] [Related]
8. Homogeneity of active demyelinating lesions in established multiple sclerosis.
Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
[TBL] [Abstract][Full Text] [Related]
9. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
[TBL] [Abstract][Full Text] [Related]
10. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
Taranova NP; Kirchik OS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
[No Abstract] [Full Text] [Related]
11. Characterization of antioligodendrocyte serum.
Traugott U; Snyder S; Norton WT; Raine CS
Ann Neurol; 1978 Nov; 4(5):431-9. PubMed ID: 367262
[TBL] [Abstract][Full Text] [Related]
12. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.
Halstead SK; O'Hanlon GM; Humphreys PD; Morrison DB; Morgan BP; Todd AJ; Plomp JJ; Willison HJ
Brain; 2004 Sep; 127(Pt 9):2109-23. PubMed ID: 15289269
[TBL] [Abstract][Full Text] [Related]
13. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing.
Zajicek JP; Wing M; Scolding NJ; Compston DA
Brain; 1992 Dec; 115 ( Pt 6)():1611-31. PubMed ID: 1486453
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies.
Scolding NJ; Compston DA
Immunology; 1991 Jan; 72(1):127-32. PubMed ID: 1997396
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.
Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H
Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.
Wren DR; Noble M
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):9025-9. PubMed ID: 2813437
[TBL] [Abstract][Full Text] [Related]
17. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrocyte susceptibility to injury by T-cell perforin.
Scolding NJ; Jones J; Compston DA; Morgan BP
Immunology; 1990 May; 70(1):6-10. PubMed ID: 2354862
[TBL] [Abstract][Full Text] [Related]
19. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.
Micu I; Jiang Q; Coderre E; Ridsdale A; Zhang L; Woulfe J; Yin X; Trapp BD; McRory JE; Rehak R; Zamponi GW; Wang W; Stys PK
Nature; 2006 Feb; 439(7079):988-92. PubMed ID: 16372019
[TBL] [Abstract][Full Text] [Related]
20. Activation of kainate receptors sensitizes oligodendrocytes to complement attack.
Alberdi E; Sánchez-Gómez MV; Torre I; Domercq M; Pérez-Samartín A; Pérez-Cerdá F; Matute C
J Neurosci; 2006 Mar; 26(12):3220-8. PubMed ID: 16554473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
